Clinical Trials Browser

Interventional × Deafness × 90 days × Clear all

NCT01451853 2026-06-03

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

Phase 2 Withdrawn

Head & NeckThoracic

Ototoxicity, Deafness, Head and Neck Neoplasms, Lung Neoplasms, Tinnitus, Hearing Loss

NCT06492993 2026-04-02

Using Community Health Navigators to Advance Cancer Screening Adherence

Phase NA Completed

Deafness, Neoplasms